Back to Search Start Over

Three-Month Clinical Outcomes to Correct Myopia or Myopic Astigmatism Using a Femtosecond Laser for Lenticule Creation With Automated Centration and Cyclotorsion Compensation.

Authors :
Yoon, Hyosung
Magnago, Thomas
Yeom, Donjg-Ju
Source :
Journal of Refractive Surgery; Jan2024, Vol. 40 Issue 1, pe30-e41, 12p
Publication Year :
2024

Abstract

Purpose: To individually evaluate the clinical outcomes for right and left eyes in the first 3 months after laser-assisted lenticule extraction for myopia and myopic astigmatism with the use of the new ATOS femtosecond laser system (Smart-Sight; SCHWIND eye-tech-solutions). Methods: A total of 331 eyes from 168 patients (166 right eyes and 165 left eyes) consecutively treated with SmartSight lenticule extraction were retrospective analyzed after a 3-month follow-up period. Patients' mean age was 26 ± 6 years (range: 18 to 47 years) and mean preoperative spherical equivalent (SEQ) was −5.07 ± 1.92 diopters [D] (range: −1.50 to −11.25 D) with a mean astigmatism of −1.04 ± 0.85 D (range: 0.00 to −4.00 D). At 3 months of follow-up, visual acuity, SEQ and cylinder, safety index, efficacy index, corneal higher order aberrations, and intraocular pressure (IOP) were analyzed. Furthermore, refractive and visual outcomes were also analyzed for the right and left eyes individually. All lenticule extraction treatments were performed with the SmartSight treatment method of the SCHWIND ATOS femtosecond laser. Results: At 3 months after surgery, mean SEQ was −0.12 ± 0.19 D and 98% of eyes were within ±0.50 D of the SEQ. All eyes were within ±1.00 D of the SEQ. Astigmatism of 0.50 D or less was achieved in 99% of eyes. The change in Snellen lines (difference between preoperative corrected distance visual acuity and postoperative uncorrected distance visual acuity) showed a gain of one or more lines in 13% and in 85% of the eyes the same was achieved. There was a loss of one or more lines at 3 months of follow-up in 1.6%. The safety index was 1.03 and efficacy index was 1.02. No significant difference between the right and left eyes was found. Conclusions: The 3-month follow-up data show that SmartSight treatment for correction of myopia and myopic astigmatism with the SCHWIND ATOS is a safe, efficient, and accurate procedure. It provided excellent results in terms of visual recovery, predictability, and higher order aberrations. [J Refract Surg. 2024;40(1):e30–e41.] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1081597X
Volume :
40
Issue :
1
Database :
Complementary Index
Journal :
Journal of Refractive Surgery
Publication Type :
Academic Journal
Accession number :
174667922
Full Text :
https://doi.org/10.3928/1081597X-20231212-03